Also noted Alfred has quickly moved to first imaging. Also Johns Hopkins was a later addition to the trials list but has two separate trials both at final imaging. I’d suggest this is positive as they quickly realised how good this is. A glowing review from them could also be helpful to appease the medical industry as a whole as to validating the technology.
Ann: Completion of first commercial scans at I-MED, page-14
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
0.030(6.25%) |
Mkt cap ! $209.7M | |||
| Open | High | Low | Value | Volume |
| 53.5¢ | 54.0¢ | 49.0¢ | $829.2K | 1.600M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 64999 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |